Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic stem cell transplantation for children, adolescents and young adults with relapsed or refractory AML
2007-004517-34Phase 3Completed
- Sponsor
- Hannover Medical School
- Start
- Apr 2008
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label trial of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia (AML) (2 arms), sponsored by Hannover Medical School. Primary endpoint: Overall survival from relapse or nonresponse. Started Apr 2008; status: completed.
02
Drugs
allogeneic hematopoietic stem cell transplantation
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on 2007-004517-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004517-34.